Fem-Dophilus 1 Billion CFU / 30 Caps - 0

• Stable version of Fem-Dophilus: No refrigeration required
• Clinically proven benefits
• 25+ years of research and clinical studies on vaginal and urinary tract health
• More than 20 studies demonstrating safety and efficacy
• Patented lactobacillus strains: GR-1® and RC-14®
• Prevention Magazine: Top 10 Breakthroughs of 2007

Fem-Dophilus® contains two patented and clinically proven probiotic strains, Lacticaseibacillus rhamnosus GR-1® and Limosilactobacillus reuteri RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health. A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic survival of bacteria in the lower intestine.

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group had a significant improvement in the composition of the vaginal flora, while only 34% of women in the placebo (non-probiotic) group had a similar improvement.

Directions: For maintenance, take 1 capsule orally daily, preferably with food and a glass of water, and increase to 2 capsules daily as needed or as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product with antibiotics, take at least 1-2 hours after taking the medication.